Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 712-722
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.712
Figure 5
Figure 5 Correlation of nonalcoholic fatty liver disease activity score with serum lipopolysaccharide-binding protein (A) and EndoCab IgG (B) in 126 biopsy-proven nonalcoholic fatty liver disease patients. Correlation efficients (r) and P values were calculated using Spearman’s test. LBP: Lipopolysaccharide-binding protein; NAS: Nonalcoholic fatty liver disease activity score.